Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study
[...]we rejected the hypothesis of microbial composition independence among pre- and post-intervention observations from the same patient, which stresses the importance of accounting for a paired data setting in the downstream analysis (results obtained at family taxonomic level, Figure 1B). SEE PDF...
Gespeichert in:
| Veröffentlicht in: | Clinical and Translational Medicine 2021-11, Vol.11 (11), p.e575-n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 11 |
| container_start_page | e575 |
| container_title | Clinical and Translational Medicine |
| container_volume | 11 |
| creator | Rodríguez‐Peña, M‐Mar Astiarraga, Brenno Seco, Jesus Ceperuelo‐Mallafré, Victoria Caballé, Adrià Pérez‐Brocal, Vicente Attolini, Camille Stephan‐Otto Moya, Andrés Llauradó, Gemma Megía, Ana Pellitero, Silvia Vilarrasa, Núria Fernández‐Veledo, Sonia Vendrell, Joan |
| description | [...]we rejected the hypothesis of microbial composition independence among pre- and post-intervention observations from the same patient, which stresses the importance of accounting for a paired data setting in the downstream analysis (results obtained at family taxonomic level, Figure 1B). SEE PDF] Our results lead us to consider that while diet-induced weight loss impacts gut microbiota composition, and the global metabolic regulation of microbial community interactions maintains a balanced ecosystem. [...]our study shows that GLP secretion, which is dependent on body weight and metabolic status, is linked to specific gut microbiota. |
| doi_str_mv | 10.1002/ctm2.575 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A693519736</galeid><doaj_id>oai_doaj_org_article_5fba93acbb654bf096084f04bf8708bf</doaj_id><sourcerecordid>A693519736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5015-b35b66ba1087f14c63d36a4aaa81f96e9e6c7a8aaef27fbc2b983fca7cfad2d23</originalsourceid><addsrcrecordid>eNp1ks1u1DAQgCMEolWpxBMgS1y4bLGdxEk4IFUrfioVcSlna-yMsy5ZO9jOrvbGI_BSvAhPgrdbSotEfIg1_vx5PJ6ieM7oGaOUv9Zpzc_qpn5UHHNK2YKVXDy-Nz8qTmO8pvlrq65r-NPiqKzaijWsPS5-LlfgBozEOjKMs4bBu1_ff4z2K5IJp2R7JIyA6wknI25wvCEn9NOIZGvTiniF0aYdAZMwECC9xZQN1vWzxp5s0Q6rfWD0cb83Qxt0yXpHICAJOELKWPJ5a5xQW2M1WVsdvLI-5ZgdHKQ54BtyTqbg90yyGyTar3xIJKa53z0rnhgYI57e_k-KL-_fXS0_Li4_f7hYnl8udE1ZvVBlrYRQwGjbGFZpUfalgAoAWmY6gR0K3UALgIY3RmmuurY0GhptoOc9L0-Ki4O393Atp2DXEHbSg5U3AR8GCSFZPaKsjYKuBK2UqCtlaCdy-Q3N07ahrTLZ9fbgmma1xl7nogQYH0gfrji7koPfyLZuWFc1WfDqVhD8txljkmsbNY4jOPRzlFzQqhKiYl1GX_6DXvs5uFwqyZucGKv5DXV2oAbIF7DO-HyuzqPH_CDeobE5fi66smZdU4q_GeTXijGgucueUbnvTbnvTZl7M6Mv7t_2DvzTiRlYHIBtPmT3X5FcXn3ie-FvsHT1hA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2760815219</pqid></control><display><type>article</type><title>Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study</title><source>Wiley-Blackwell Open Access Collection</source><source>MEDLINE</source><source>Wiley Journals</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Rodríguez‐Peña, M‐Mar ; Astiarraga, Brenno ; Seco, Jesus ; Ceperuelo‐Mallafré, Victoria ; Caballé, Adrià ; Pérez‐Brocal, Vicente ; Attolini, Camille Stephan‐Otto ; Moya, Andrés ; Llauradó, Gemma ; Megía, Ana ; Pellitero, Silvia ; Vilarrasa, Núria ; Fernández‐Veledo, Sonia ; Vendrell, Joan</creator><creatorcontrib>Rodríguez‐Peña, M‐Mar ; Astiarraga, Brenno ; Seco, Jesus ; Ceperuelo‐Mallafré, Victoria ; Caballé, Adrià ; Pérez‐Brocal, Vicente ; Attolini, Camille Stephan‐Otto ; Moya, Andrés ; Llauradó, Gemma ; Megía, Ana ; Pellitero, Silvia ; Vilarrasa, Núria ; Fernández‐Veledo, Sonia ; Vendrell, Joan</creatorcontrib><description>[...]we rejected the hypothesis of microbial composition independence among pre- and post-intervention observations from the same patient, which stresses the importance of accounting for a paired data setting in the downstream analysis (results obtained at family taxonomic level, Figure 1B). SEE PDF] Our results lead us to consider that while diet-induced weight loss impacts gut microbiota composition, and the global metabolic regulation of microbial community interactions maintains a balanced ecosystem. [...]our study shows that GLP secretion, which is dependent on body weight and metabolic status, is linked to specific gut microbiota.</description><identifier>ISSN: 2001-1326</identifier><identifier>EISSN: 2001-1326</identifier><identifier>DOI: 10.1002/ctm2.575</identifier><identifier>PMID: 34841718</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Adult ; Analysis ; Cohort Studies ; Conflicts of interest ; Data analysis ; Diet ; Female ; Genes ; Glucagon ; Glucagon-Like Peptide 1 - metabolism ; Glucagon-Like Peptide 1 - pharmacology ; Glucagon-Like Peptide 1 - therapeutic use ; Glucagon-Like Peptide 2 - metabolism ; Glucagon-Like Peptide 2 - pharmacology ; Glucagon-Like Peptide 2 - therapeutic use ; Grants ; Humans ; Letter to the Editor ; Male ; Metabolism ; Microbiota ; Microbiota (Symbiotic organisms) ; Microbiota - drug effects ; Microbiota - physiology ; Middle Aged ; Obesity ; Obesity - diet therapy ; Obesity - drug therapy ; Patients ; Peptides ; Prospective Studies ; Statistical analysis ; Taxonomy ; Weight control ; Weight loss ; Weight Reduction Programs - methods ; Weight Reduction Programs - standards ; Weight Reduction Programs - statistics & numerical data</subject><ispartof>Clinical and Translational Medicine, 2021-11, Vol.11 (11), p.e575-n/a</ispartof><rights>2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics</rights><rights>COPYRIGHT 2021 John Wiley & Sons, Inc.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5015-b35b66ba1087f14c63d36a4aaa81f96e9e6c7a8aaef27fbc2b983fca7cfad2d23</citedby><cites>FETCH-LOGICAL-c5015-b35b66ba1087f14c63d36a4aaa81f96e9e6c7a8aaef27fbc2b983fca7cfad2d23</cites><orcidid>0000-0002-6994-6115 ; 0000-0003-2553-9769 ; 0000-0003-2216-8974 ; 0000-0002-4049-8873 ; 0000-0002-5101-9452 ; 0000-0002-4460-9761 ; 0000-0003-2906-3788</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571947/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571947/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,2102,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34841718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodríguez‐Peña, M‐Mar</creatorcontrib><creatorcontrib>Astiarraga, Brenno</creatorcontrib><creatorcontrib>Seco, Jesus</creatorcontrib><creatorcontrib>Ceperuelo‐Mallafré, Victoria</creatorcontrib><creatorcontrib>Caballé, Adrià</creatorcontrib><creatorcontrib>Pérez‐Brocal, Vicente</creatorcontrib><creatorcontrib>Attolini, Camille Stephan‐Otto</creatorcontrib><creatorcontrib>Moya, Andrés</creatorcontrib><creatorcontrib>Llauradó, Gemma</creatorcontrib><creatorcontrib>Megía, Ana</creatorcontrib><creatorcontrib>Pellitero, Silvia</creatorcontrib><creatorcontrib>Vilarrasa, Núria</creatorcontrib><creatorcontrib>Fernández‐Veledo, Sonia</creatorcontrib><creatorcontrib>Vendrell, Joan</creatorcontrib><title>Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study</title><title>Clinical and Translational Medicine</title><addtitle>Clin Transl Med</addtitle><description>[...]we rejected the hypothesis of microbial composition independence among pre- and post-intervention observations from the same patient, which stresses the importance of accounting for a paired data setting in the downstream analysis (results obtained at family taxonomic level, Figure 1B). SEE PDF] Our results lead us to consider that while diet-induced weight loss impacts gut microbiota composition, and the global metabolic regulation of microbial community interactions maintains a balanced ecosystem. [...]our study shows that GLP secretion, which is dependent on body weight and metabolic status, is linked to specific gut microbiota.</description><subject>Adult</subject><subject>Analysis</subject><subject>Cohort Studies</subject><subject>Conflicts of interest</subject><subject>Data analysis</subject><subject>Diet</subject><subject>Female</subject><subject>Genes</subject><subject>Glucagon</subject><subject>Glucagon-Like Peptide 1 - metabolism</subject><subject>Glucagon-Like Peptide 1 - pharmacology</subject><subject>Glucagon-Like Peptide 1 - therapeutic use</subject><subject>Glucagon-Like Peptide 2 - metabolism</subject><subject>Glucagon-Like Peptide 2 - pharmacology</subject><subject>Glucagon-Like Peptide 2 - therapeutic use</subject><subject>Grants</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Male</subject><subject>Metabolism</subject><subject>Microbiota</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Microbiota - drug effects</subject><subject>Microbiota - physiology</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - diet therapy</subject><subject>Obesity - drug therapy</subject><subject>Patients</subject><subject>Peptides</subject><subject>Prospective Studies</subject><subject>Statistical analysis</subject><subject>Taxonomy</subject><subject>Weight control</subject><subject>Weight loss</subject><subject>Weight Reduction Programs - methods</subject><subject>Weight Reduction Programs - standards</subject><subject>Weight Reduction Programs - statistics & numerical data</subject><issn>2001-1326</issn><issn>2001-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks1u1DAQgCMEolWpxBMgS1y4bLGdxEk4IFUrfioVcSlna-yMsy5ZO9jOrvbGI_BSvAhPgrdbSotEfIg1_vx5PJ6ieM7oGaOUv9Zpzc_qpn5UHHNK2YKVXDy-Nz8qTmO8pvlrq65r-NPiqKzaijWsPS5-LlfgBozEOjKMs4bBu1_ff4z2K5IJp2R7JIyA6wknI25wvCEn9NOIZGvTiniF0aYdAZMwECC9xZQN1vWzxp5s0Q6rfWD0cb83Qxt0yXpHICAJOELKWPJ5a5xQW2M1WVsdvLI-5ZgdHKQ54BtyTqbg90yyGyTar3xIJKa53z0rnhgYI57e_k-KL-_fXS0_Li4_f7hYnl8udE1ZvVBlrYRQwGjbGFZpUfalgAoAWmY6gR0K3UALgIY3RmmuurY0GhptoOc9L0-Ki4O393Atp2DXEHbSg5U3AR8GCSFZPaKsjYKuBK2UqCtlaCdy-Q3N07ahrTLZ9fbgmma1xl7nogQYH0gfrji7koPfyLZuWFc1WfDqVhD8txljkmsbNY4jOPRzlFzQqhKiYl1GX_6DXvs5uFwqyZucGKv5DXV2oAbIF7DO-HyuzqPH_CDeobE5fi66smZdU4q_GeTXijGgucueUbnvTbnvTZl7M6Mv7t_2DvzTiRlYHIBtPmT3X5FcXn3ie-FvsHT1hA</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Rodríguez‐Peña, M‐Mar</creator><creator>Astiarraga, Brenno</creator><creator>Seco, Jesus</creator><creator>Ceperuelo‐Mallafré, Victoria</creator><creator>Caballé, Adrià</creator><creator>Pérez‐Brocal, Vicente</creator><creator>Attolini, Camille Stephan‐Otto</creator><creator>Moya, Andrés</creator><creator>Llauradó, Gemma</creator><creator>Megía, Ana</creator><creator>Pellitero, Silvia</creator><creator>Vilarrasa, Núria</creator><creator>Fernández‐Veledo, Sonia</creator><creator>Vendrell, Joan</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6994-6115</orcidid><orcidid>https://orcid.org/0000-0003-2553-9769</orcidid><orcidid>https://orcid.org/0000-0003-2216-8974</orcidid><orcidid>https://orcid.org/0000-0002-4049-8873</orcidid><orcidid>https://orcid.org/0000-0002-5101-9452</orcidid><orcidid>https://orcid.org/0000-0002-4460-9761</orcidid><orcidid>https://orcid.org/0000-0003-2906-3788</orcidid></search><sort><creationdate>202111</creationdate><title>Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study</title><author>Rodríguez‐Peña, M‐Mar ; Astiarraga, Brenno ; Seco, Jesus ; Ceperuelo‐Mallafré, Victoria ; Caballé, Adrià ; Pérez‐Brocal, Vicente ; Attolini, Camille Stephan‐Otto ; Moya, Andrés ; Llauradó, Gemma ; Megía, Ana ; Pellitero, Silvia ; Vilarrasa, Núria ; Fernández‐Veledo, Sonia ; Vendrell, Joan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5015-b35b66ba1087f14c63d36a4aaa81f96e9e6c7a8aaef27fbc2b983fca7cfad2d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Analysis</topic><topic>Cohort Studies</topic><topic>Conflicts of interest</topic><topic>Data analysis</topic><topic>Diet</topic><topic>Female</topic><topic>Genes</topic><topic>Glucagon</topic><topic>Glucagon-Like Peptide 1 - metabolism</topic><topic>Glucagon-Like Peptide 1 - pharmacology</topic><topic>Glucagon-Like Peptide 1 - therapeutic use</topic><topic>Glucagon-Like Peptide 2 - metabolism</topic><topic>Glucagon-Like Peptide 2 - pharmacology</topic><topic>Glucagon-Like Peptide 2 - therapeutic use</topic><topic>Grants</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Male</topic><topic>Metabolism</topic><topic>Microbiota</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Microbiota - drug effects</topic><topic>Microbiota - physiology</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - diet therapy</topic><topic>Obesity - drug therapy</topic><topic>Patients</topic><topic>Peptides</topic><topic>Prospective Studies</topic><topic>Statistical analysis</topic><topic>Taxonomy</topic><topic>Weight control</topic><topic>Weight loss</topic><topic>Weight Reduction Programs - methods</topic><topic>Weight Reduction Programs - standards</topic><topic>Weight Reduction Programs - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodríguez‐Peña, M‐Mar</creatorcontrib><creatorcontrib>Astiarraga, Brenno</creatorcontrib><creatorcontrib>Seco, Jesus</creatorcontrib><creatorcontrib>Ceperuelo‐Mallafré, Victoria</creatorcontrib><creatorcontrib>Caballé, Adrià</creatorcontrib><creatorcontrib>Pérez‐Brocal, Vicente</creatorcontrib><creatorcontrib>Attolini, Camille Stephan‐Otto</creatorcontrib><creatorcontrib>Moya, Andrés</creatorcontrib><creatorcontrib>Llauradó, Gemma</creatorcontrib><creatorcontrib>Megía, Ana</creatorcontrib><creatorcontrib>Pellitero, Silvia</creatorcontrib><creatorcontrib>Vilarrasa, Núria</creatorcontrib><creatorcontrib>Fernández‐Veledo, Sonia</creatorcontrib><creatorcontrib>Vendrell, Joan</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Free Archive</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical and Translational Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodríguez‐Peña, M‐Mar</au><au>Astiarraga, Brenno</au><au>Seco, Jesus</au><au>Ceperuelo‐Mallafré, Victoria</au><au>Caballé, Adrià</au><au>Pérez‐Brocal, Vicente</au><au>Attolini, Camille Stephan‐Otto</au><au>Moya, Andrés</au><au>Llauradó, Gemma</au><au>Megía, Ana</au><au>Pellitero, Silvia</au><au>Vilarrasa, Núria</au><au>Fernández‐Veledo, Sonia</au><au>Vendrell, Joan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study</atitle><jtitle>Clinical and Translational Medicine</jtitle><addtitle>Clin Transl Med</addtitle><date>2021-11</date><risdate>2021</risdate><volume>11</volume><issue>11</issue><spage>e575</spage><epage>n/a</epage><pages>e575-n/a</pages><issn>2001-1326</issn><eissn>2001-1326</eissn><abstract>[...]we rejected the hypothesis of microbial composition independence among pre- and post-intervention observations from the same patient, which stresses the importance of accounting for a paired data setting in the downstream analysis (results obtained at family taxonomic level, Figure 1B). SEE PDF] Our results lead us to consider that while diet-induced weight loss impacts gut microbiota composition, and the global metabolic regulation of microbial community interactions maintains a balanced ecosystem. [...]our study shows that GLP secretion, which is dependent on body weight and metabolic status, is linked to specific gut microbiota.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>34841718</pmid><doi>10.1002/ctm2.575</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6994-6115</orcidid><orcidid>https://orcid.org/0000-0003-2553-9769</orcidid><orcidid>https://orcid.org/0000-0003-2216-8974</orcidid><orcidid>https://orcid.org/0000-0002-4049-8873</orcidid><orcidid>https://orcid.org/0000-0002-5101-9452</orcidid><orcidid>https://orcid.org/0000-0002-4460-9761</orcidid><orcidid>https://orcid.org/0000-0003-2906-3788</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2001-1326 |
| ispartof | Clinical and Translational Medicine, 2021-11, Vol.11 (11), p.e575-n/a |
| issn | 2001-1326 2001-1326 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571947 |
| source | Wiley-Blackwell Open Access Collection; MEDLINE; Wiley Journals; DOAJ Directory of Open Access Journals; PubMed Central; EZB Electronic Journals Library |
| subjects | Adult Analysis Cohort Studies Conflicts of interest Data analysis Diet Female Genes Glucagon Glucagon-Like Peptide 1 - metabolism Glucagon-Like Peptide 1 - pharmacology Glucagon-Like Peptide 1 - therapeutic use Glucagon-Like Peptide 2 - metabolism Glucagon-Like Peptide 2 - pharmacology Glucagon-Like Peptide 2 - therapeutic use Grants Humans Letter to the Editor Male Metabolism Microbiota Microbiota (Symbiotic organisms) Microbiota - drug effects Microbiota - physiology Middle Aged Obesity Obesity - diet therapy Obesity - drug therapy Patients Peptides Prospective Studies Statistical analysis Taxonomy Weight control Weight loss Weight Reduction Programs - methods Weight Reduction Programs - standards Weight Reduction Programs - statistics & numerical data |
| title | Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20glucagon%E2%80%90like%20peptide%201%20and%202%20levels%20in%20people%20with%20obesity%20after%20a%20diet%E2%80%90induced%20weight%E2%80%90loss%20intervention%20are%20related%20to%20a%20specific%20microbiota%20signature:%20A%20prospective%20cohort%20study&rft.jtitle=Clinical%20and%20Translational%20Medicine&rft.au=Rodr%C3%ADguez%E2%80%90Pe%C3%B1a,%20M%E2%80%90Mar&rft.date=2021-11&rft.volume=11&rft.issue=11&rft.spage=e575&rft.epage=n/a&rft.pages=e575-n/a&rft.issn=2001-1326&rft.eissn=2001-1326&rft_id=info:doi/10.1002/ctm2.575&rft_dat=%3Cgale_doaj_%3EA693519736%3C/gale_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2760815219&rft_id=info:pmid/34841718&rft_galeid=A693519736&rft_doaj_id=oai_doaj_org_article_5fba93acbb654bf096084f04bf8708bf&rfr_iscdi=true |